Eli Lilly and Company

Pharmaceutical Sales Representatives - GTA | Toronto

Canada

Not SpecifiedCompensation
Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

Candidates should possess a Bachelor's degree in a related field, along with a strong understanding of pharmaceutical sales principles and a proven ability to build and maintain relationships with healthcare professionals, hospitals, and clinics. They should demonstrate experience in developing territory business plans, possessing deep product knowledge, and adhering to ethical sales practices and industry regulations.

Responsibilities

As a Pharmaceutical Sales Representative, the individual will be responsible for account management, driving sales growth, promoting innovative therapies, collaborating with cross-functional teams, gathering insights, and effectively educating and engaging healthcare professionals to ensure the success of brand strategies and improve patient care.

Skills

Relationship Building
Sales Strategy
Product Knowledge
Collaboration
Integrity & Compliance
Flexibility & Adaptability
Territory Business Planning
Healthcare Professional Engagement
Insight Gathering

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI